Financial
FY2025/26 revenue SEK 3.54bn (+9.3%); operating margin 20.1%; net income SEK 563.8m.
Prior year included a SEK 110m one-off patent settlement.
HQ Sweden · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
FY2025/26 revenue SEK 3.54bn (+9.3%); operating margin 20.1%; net income SEK 563.8m.
Prior year included a SEK 110m one-off patent settlement.
Source: official results release · Year ended 2026-04-30 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025/26 | SEK 3.5bn | +9.3% | SEK 710.6m | SEK 563.8m | Sectra |
Products not yet catalogued.
FY2025/26 revenue SEK 3.54bn (+9.3%); operating margin 20.1%; net income SEK 563.8m.
Prior year included a SEK 110m one-off patent settlement.
No adverse media involving Sectra found in HSH's search of the last 24 months.
Oct 2025: Sectra notified customers of a critical security vulnerability in several Sectra Core versions that could affect confidentiality, integrity and availability of patient data; Health Canada listed it as a Type II recall and France's ANSM published a safety notice. NHS DSPT status not yet checked.
Oct 2025: the Sectra Core security vulnerability was handled as a medical device recall/field safety action (Health Canada Type II). No other recalls or regulator actions involving Sectra found in HSH's search of the last 24 months.
Apr 2026: Sectra signed a five-year, £15.6m Sectra One Cloud contract with six north central London NHS trusts, consolidating seven imaging systems. In Apr 2025 Children's Health Ireland signed a five-year deal with Sectra.
No competitors linked yet.